This year's edition

SensUs 2020

This is the fifth year of the SensUs Student Competition. The Organization will challenge 16 Teams from all over the world to develop innovative biosensing systems for the treatment of epilepsy, measuring the biomarker unbound valproate. On the 28th of August, the Teams will present and demonstrate their biosensor to the world in our first fully online Event. This year will be bigger than previous editions, we hope to see you there!

Experience SensUs 2020 live on SensUs Digital. Our online platform features a livestream, live results, Team Pages and more.

SensUs Digital
Market SensUs 2019
For students, by students

An international competition

SensUs is a yearly international Student Competition on sensors for health. By involving students, industry, and health partners we strive to accelerate the development of sensors for better healthcare.

During SensUs 2020, students from all over the world compete to make biosensors for measuring unbound valproate, a drug that is used to treat epilepsy. All Teams will showcase their biosensors on the 28th of August during the SensUs Event. The biosensors will be judged on multiple criteria such as analytical performance, creativity, and industrialization potential. This will be done by representatives of academia, industry, and healthcare.

learn more

About biosensing

What is a biosensor?
Benefits of a biosensor
The future of biosensing
Learn more
Our goals and objectives

What is SensUs?


In the future, healthcare will be all about personalized medicine, monitoring health with small and precise systems at any time.


Stimulate the development of sensors for health in a friendly competitive manner whereby students make and design innovative biosensors.


Each year, a societally impactful disease and molecular marker are chosen as objective in collaboration with different stakeholders.
Stay updated

Latest news

New Members 2021
New Members 2021
New Members 2021
SensUs interviews Dr Richard Lazeron
SensUs interviews Dr Richard Lazeron
SensUs interviews Dr Richard Lazeron
More news
Sensus is made possible by

Our partners

Want to learn more about the benefits of becoming a partner? Partners